Literature DB >> 24862700

Chronic overcirculation-induced pulmonary arterial hypertension in aorto-caval shunt.

Alessio Rungatscher1, Daniele Linardi2, Elisabetta Milani2, Grazia Ucci3, Elena Nicolato4, Flavia Merigo4, Beatrice Salvetti4, Alessandro Mazzucco2, Giovanni Battista Luciani2, Giuseppe Faggian2.   

Abstract

Pulmonary arterial hypertension is a common complication of congenital heart defects with left-to-right shunts. Current preclinical models do not reproduce clinical characteristics of shunt-related pulmonary hypertension. Aorto-caval shunt was firstly described as a model of right ventricle volume overload. The pathophysiology and the possible determination of pulmonary arterial hypertension of different periods of shunt exposure are still undefined. A method to create standardized, reproducible aorto-caval shunt was developed in growing rats (260±40 g). Three groups of animals were considered: shunt exposure for 10 weeks, shunt exposure for 20 weeks and control (sham laparotomy). Echocardiography and magnetic resonance revealed increased right ventricular end diastolic area in shunt at 10 weeks compared to control. Hemodynamic analysis demonstrated increased right ventricular afterload and increased effective pulmonary arterial elastance (Ea) in shunt at 20 weeks compared to control (1.29±0.20 vs. 0.14±0.06 mmHg/μl, p=0.004). At the same time point, the maximal slope of end-systolic pressure-volume relationship (Ees) decreased (0.5±0.2 mmHg/ml vs. 1.2±0.3, p<0.001). Consequently, right ventricular-arterial coupling was markedly deteriorated with a ≈50% decrease in the ratio of end-systolic to pulmonary artery elastance (Ees/Ea). Finally, left ventricular preload diminished (≈30% decrease in left ventricular end-diastolic volume). Histology demonstrated medial hypertrophy and small artery luminal narrowing. Chronic exposure to aorto-caval shunt is a reliable model to produce right ventricular volume overload and secondary pulmonary arterial hypertension. This model could be an alternative with low mortality and high reproducibility for investigators on the underlying mechanisms of shunt-related pulmonary hypertension.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aorto-caval shunt; Experimental model; Pressure-volume loops; Pulmonary arterial hypertension; Rats; Right ventricle overload; Vascular remodeling; Ventricular interdependence; Ventricular vascular coupling; Volume overload

Mesh:

Year:  2014        PMID: 24862700     DOI: 10.1016/j.mvr.2014.05.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  4 in total

1.  Cellular senescence impairs the reversibility of pulmonary arterial hypertension.

Authors:  Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

2.  Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

Authors:  Diederik E van der Feen; Michel Weij; Annemieke Smit-van Oosten; Lysanne M Jorna; Quint A J Hagdorn; Beatrijs Bartelds; Rolf M F Berger
Journal:  J Vis Exp       Date:  2017-02-11       Impact factor: 1.355

3.  Reduced Forced Vital Capacity and the Number of Chest Wall Surgeries are Associated with Decreased Exercise Capacity in Children with Congenital Heart Disease.

Authors:  Imran R Masood; Jon Detterich; Daniel Cerrone; Katherine Lewinter; Payal Shah; Roberta Kato; Arash Sabati
Journal:  Pediatr Cardiol       Date:  2021-08-07       Impact factor: 1.655

4.  Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension.

Authors:  Mingjie Zhang; Zhiyu Feng; Rui Huang; Chongrui Sun; Zhuoming Xu
Journal:  Med Sci Monit       Date:  2018-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.